Skip to main content
NIH funding notice RFA-HL-25-010

Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Clinical Coordinating Center (Collaborative UG3/UH3 Clinical Trial Required)

Closed on October 28, 2024.

Posted
July 10, 2024
Close date
October 28, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$3,886,403
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. DUKE UNIVERSITY1

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-Q (M1))1
1 award under RFA-HL-25-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY20251/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis1UG3HL181434-01Alexander, Karen PDouglas, Pamela SusanPagidipati, Neha JadejaDUKE UNIVERSITY, NCFirst-year cost $3,886,403Study section ZHL1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.